DARK HORSE CONSULTING GROUP, INC.

DARK HORSE CONSULTING GROUP, INC. specializes in providing scientific and technical consulting services focused on biologics development and regulatory science, with deep expertise in supporting complex biopharmaceutical workflows. The firm delivers subject matter expert advisory services to federal agencies engaged in life sciences oversight, particularly in areas such as product characterization, manufacturing process validation, and regulatory strategy alignment. Their technical capabilities include navigating FDA regulatory frameworks, evaluating clinical trial data integrity, and advising on biosimilar and biologic license application pathways. The company differentiates itself through its targeted application of domain-specific knowledge in biologics, enabling agencies to accelerate decision-making while maintaining compliance with current Good Manufacturing Practices and international harmonization standards. The contractor has demonstrated direct engagement with the Department of Health and Human Services, primarily supporting mission-critical functions related to biologics regulation and scientific review. This relationship suggests a focus on agencies within HHS such as the Center for Biologics Evaluation and Research, where technical advisory services are essential for evaluating novel therapeutics and ensuring public health safety. Their primary industry focus lies in Other Scientific and Technical Consulting Services, specifically serving the biopharmaceutical and regulatory science verticals. This positions them as a niche provider for federal entities requiring specialized expertise in advanced therapeutics, rather than broad-based IT or engineering consulting. DARK HORSE CONSULTING GROUP, INC. is a small business structured as a 2L entity, headquartered in Walnut Creek, California. While currently holding no formal government certifications, its geographic proximity to major biotech hubs and federal science centers enhances its ability to deliver responsive, on-site technical support to federal stakeholders in the life sciences sector.